{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:29:37Z","timestamp":1791322177579,"version":"4.3.1"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1005483","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T18:05:08Z","timestamp":1459447508000},"page":"e1005483","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine"],"prefix":"10.1371","volume":"12","author":[{"given":"Barbara P.","family":"Sanders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"de los Rios Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"van Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viki","family":"Bockstal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taco G.","family":"Uil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Crawt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckard","family":"Wimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome H. H. V.","family":"Custers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Schuitemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeronimo","family":"Cello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Edo-Matas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jama.1953.13.1081","article-title":"Studies in human subjects on active immunization against poliomyelitis. I. A preliminary report of experiments in progress","volume":"151","author":"JE Salk","year":"1953","journal-title":"J Am Med Assoc"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1749-6632.1955.tb42565.x","article-title":"Immunization of chimpanzees and human beings with avirulent strains of poliomyelitis virus","volume":"61","author":"AB Sabin","year":"1955","journal-title":"Ann N Y Acad Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/archinte.1960.03820010007003","article-title":"Oral, live poliovirus vaccine for elimination of poliomyelitis","volume":"106","author":"AB Sabin","year":"1960","journal-title":"Arch Intern Med"},{"key":"ref4","unstructured":"WHO (2015) Polio This Week: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek.aspx\" xlink:type=\"simple\">http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek.aspx<\/ext-link>. In: Organization GPEIWH, editor."},{"key":"ref5","first-page":"1335","article-title":"Paralytic disease associated with oral Polio vaccines","volume":"13","author":"DA WJ Henderson","year":"1964","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication","volume":"27","author":"P Minor","year":"2009","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1586\/erv.12.28","article-title":"Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis","volume":"11","author":"V Pliaka","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"ref8","unstructured":"WHO (2013) Polio Eradication &amp; Endgame Strategic Plan 2013\u20132018. Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/StrategyWork\/PEESP_EN_US.pdf\" xlink:type=\"simple\">http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/StrategyWork\/PEESP_EN_US.pdf<\/ext-link>."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/14760584.2014.864563","article-title":"National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication","volume":"13","author":"KM Thompson","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nrmicro1769","article-title":"Vaccination against polio should not be stopped","volume":"5","author":"K Chumakov","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref11","first-page":"217","article-title":"Detection of MEF-1 laboratory reference strain of poliovirus type 2 in children with poliomyelitis in India in 2002 &amp; 2003","volume":"118","author":"JM Deshpande","year":"2003","journal-title":"Indian J Med Res"},{"key":"ref12","unstructured":"ECDC (2014) The accidental release of 45 litres of concentrated live polio virus solution into the environment\u2014Belgium European Centre for Disease Prevention and Control."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e1005114","DOI":"10.1371\/journal.ppat.1005114","article-title":"Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative","volume":"11","author":"G Dunn","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref14","first-page":"163","article-title":"Vaccination strategies for the last stages of global polio eradication","volume":"42","author":"F Bompart","year":"2005","journal-title":"Indian Pediatr"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1539-6924.2006.00844.x","article-title":"Containment of polioviruses after eradication and OPV cessation: characterizing risks to improve management","volume":"26","author":"W Dowdle","year":"2006","journal-title":"Risk Anal"},{"key":"ref16","article-title":"Recommendations for the production and control of poliomyelitis vaccine (inactivated)","year":"2002"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jit155","article-title":"Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV)","volume":"208","author":"K Okada","year":"2013","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"G Liao","year":"2012","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"WA Bakker","year":"2011","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"AS Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"key":"ref21","article-title":"sIPV process development for costs reduction","author":"YE Thomassen","year":"2015","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1016\/j.vaccine.2014.07.029","article-title":"Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants","volume":"32","author":"P Verdijk","year":"2014","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.vaccine.2011.02.085","article-title":"Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines","volume":"29","author":"J Westdijk","year":"2011","journal-title":"Vaccine"},{"key":"ref24","article-title":"Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan","author":"H Shimizu","year":"2014","journal-title":"Vaccine"},{"key":"ref25","unstructured":"Macadam A (2012) Inactivated Poliovaccine. International Patent Number: WO 2012\/090000 A1. United Kingdom."},{"key":"ref26","unstructured":"WHO (2014) WHO Technical Report Series No. 980. Annex 2 Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated). Available at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/biologicals\/IPV_FINAL_for_BS2233_07072014(2).pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/biologicals\/IPV_FINAL_for_BS2233_07072014(2).pdf<\/ext-link>. Geneva: World Health Organization."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0264-410X(85)90124-0","article-title":"Development and characterization of cold-adapted viruses for use as live virus vaccines","volume":"3","author":"HF Maassab","year":"1985","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristics of influenza virus at 25 degrees c","volume":"213","author":"HF Maassab","year":"1967","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/infdis\/136.1.17","article-title":"Pilot studies on recombinant cold-adapted live type A and B influenza virus vaccines","volume":"136","author":"FM Davenport","year":"1977","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jama.1968.03150030043009","article-title":"Development and evaluation of the Moraten measles virus vaccine","volume":"206","author":"MR Hilleman","year":"1968","journal-title":"JAMA"},{"issue":"Suppl 1","key":"ref31","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1093\/clinids\/7.Supplement_1.S77","article-title":"History of RA27\/3 rubella vaccine","volume":"7","author":"SA Plotkin","year":"1985","journal-title":"Rev Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1128\/JVI.71.6.4728-4735.1997","article-title":"Cold-adapted poliovirus mutants bypass a postentry replication block","volume":"71","author":"AW Dove","year":"1997","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0042-6822(57)90063-6","article-title":"Virulence of polioviruses in relation to variant characteristics distinguishable on cells in vitro","volume":"4","author":"GR Dubes","year":"1957","journal-title":"Virology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/MMBR.23.3.109-124.1959","article-title":"Factors influencing the evolution of viral diseases at the cellular level and in the organism","volume":"23","author":"A Lwoff","year":"1959","journal-title":"Bacteriol Rev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/JVI.64.10.4922-4929.1990","article-title":"Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature","volume":"64","author":"C Christodoulou","year":"1990","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0042-6822(89)90183-9","article-title":"Reversion of the attenuated and temperature-sensitive phenotypes of the Sabin type 3 strain of poliovirus in vaccinees","volume":"172","author":"AJ Macadam","year":"1989","journal-title":"Virology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0042-6822(91)90877-E","article-title":"The 5&apos; noncoding region of the type 2 poliovirus vaccine strain contains determinants of attenuation and temperature sensitivity","volume":"181","author":"AJ Macadam","year":"1991","journal-title":"Virology"},{"key":"ref38","article-title":"Brunenders: A partially attenuated historic poliovirus Type I vaccine strain","author":"BP Sanders","year":"2015","journal-title":"J Gen Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1073\/pnas.88.3.951","article-title":"Transgenic mice susceptible to poliovirus","volume":"88","author":"S Koike","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1073\/pnas.93.6.2370","article-title":"Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants","volume":"93","author":"M Gromeier","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcv.2009.01.014","article-title":"Oral poliovirus vaccine type 3 from a patient with transverse myelitis is neurovirulent in a transgenic mouse model","volume":"44","author":"B Thorley","year":"2009","journal-title":"J Clin Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1126\/science.124.3222.586-a","article-title":"Cold-adapted genetic variants of polio viruses","volume":"124","author":"M Chapin","year":"1956","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1128\/JVI.01804-09","article-title":"A host-specific, temperature-sensitive translation defect determines the attenuation phenotype of a human rhinovirus\/poliovirus chimera, PV1(RIPO)","volume":"85","author":"N Jahan","year":"2011","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1128\/JVI.00370-06","article-title":"Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication","volume":"80","author":"AJ Macadam","year":"2006","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1158\/0008-5472.CAN-06-3713","article-title":"Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model","volume":"67","author":"H Toyoda","year":"2007","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1126\/science.1155761","article-title":"Virus attenuation by genome-scale changes in codon pair bias","volume":"320","author":"JR Coleman","year":"2008","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nm1726","article-title":"Engineering attenuated virus vaccines by controlling replication fidelity","volume":"14","author":"M Vignuzzi","year":"2008","journal-title":"Nat Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e1005316","DOI":"10.1371\/journal.ppat.1005316","article-title":"New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication","volume":"11","author":"S Knowlson","year":"2015","journal-title":"PLoS Pathog"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1128\/JVI.65.11.5886-5894.1991","article-title":"Structural and functional analysis of the ribosome landing pad of poliovirus type 2: in vivo translation studies","volume":"65","author":"R Nicholson","year":"1991","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.71.1.1-8.1997","article-title":"Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA","volume":"71","author":"K Shiroki","year":"1997","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.71.11.8482-8489.1997","article-title":"Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C","volume":"71","author":"DJ Barton","year":"1997","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1006\/viro.1994.1329","article-title":"Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells","volume":"202","author":"MW Cho","year":"1994","journal-title":"Virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"10105","DOI":"10.1074\/jbc.270.17.10105","article-title":"Poliovirus protein 2C contains two regions involved in RNA binding activity","volume":"270","author":"PL Rodriguez","year":"1995","journal-title":"J Biol Chem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1099\/vir.0.062497-0","article-title":"A C-terminal, cysteine-rich site in poliovirus 2C(ATPase) is required for morphogenesis","volume":"95","author":"C Wang","year":"2014","journal-title":"J Gen Virol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"10359","DOI":"10.1128\/JVI.74.22.10359-10370.2000","article-title":"Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg","volume":"74","author":"AV Paul","year":"2000","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/viro.2000.0354","article-title":"Studies on the attenuation phenotype of polio vaccines: poliovirus RNA polymerase derived from Sabin type 1 sequence is temperature sensitive in the uridylylation of VPg","volume":"272","author":"AV Paul","year":"2000","journal-title":"Virology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jmb.2013.12.031","article-title":"Distinct conformations of a putative translocation element in poliovirus polymerase","volume":"426","author":"AJ Sholders","year":"2014","journal-title":"J Mol Biol"},{"key":"ref58","article-title":"Advances in Virus Research","author":"N Nathanson","year":"2008"},{"key":"ref59","article-title":"Improving the affordability of Inactivated Poliovirus Vaccines (IPV) for use in low- and middle-income countries","author":"D Zehrung","year":"2010"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.vaccine.2012.10.070","article-title":"PER.C6((R)) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine","volume":"31","author":"BP Sanders","year":"2013","journal-title":"Vaccine"},{"key":"ref61","article-title":"Production of high titer attenuated poliovirus strains on the serum-free PER.C6 cell culture platform for the generation of safe and affordable next generation IPV","author":"BP Sanders","year":"2015","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1073\/pnas.83.8.2330","article-title":"Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase","volume":"83","author":"S van der Werf","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1089\/hum.1998.9.13-1909","article-title":"New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses","volume":"9","author":"FJ Fallaux","year":"1998","journal-title":"Hum Gene Ther"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/es60130a004","article-title":"Trimmed Spearman-Karber Method for Estimating Median Lethal Concentration in Toxicity Bioassays","volume":"11","author":"M, A. Hamilton","year":"1977","journal-title":"Environmental Science and Technology"},{"key":"ref65","article-title":"Standard Operating Procedure Neurovirulence test of Types 1, 2 or 3 Live Attenuated Poliomyelitis Vaccines (Oral) in transgenic mice susceptible to poliovirus","year":"2012"},{"key":"ref66","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoint","volume":"27","author":"LJM, H. Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2105\/AJPH.44.5.563","article-title":"Formaldehyde treatment and safety testing of experimental poliomyelitis vaccines","volume":"44","author":"JE Salk","year":"1954","journal-title":"Am J Public Health Nations Health"},{"key":"ref68","first-page":"255","article-title":"European Pharmacopoeia 8th Edition","volume":"Volume 1","year":"2014"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2012.06.014","article-title":"A plate-based high-throughput assay for virus stability and vaccine formulation","volume":"185","author":"TS Walter","year":"2012","journal-title":"J Virol Methods"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1005483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T01:11:22Z","timestamp":1600391482000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1005483"}},"subtitle":[],"editor":[{"given":"Bert L.","family":"Semler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":69,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1005483","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}